RxDoctor Payments Data

Linwood Joyner, MD

Family Medicine · Nassawadox, VANPI 1336680537

Payments from drug & device makers

$404in general payments, 2019–2025

Across 24 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$92
  • Lilly USA, LLC$66
  • Pfizer$55
  • Boehringer Ingelheim$45
  • Abbott$24
  • AbbVie$24
  • plus $97 from 7 others

What the payments were for

  • Food & beverage$404100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$404 in reported general payments places this provider in the 55th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$433
Medicare patients
26
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide104$132,796
OzempicSemaglutide97$118,510
EliquisApixaban84$95,121
JardianceEmpagliflozin39$50,006
JanuviaSitagliptin Phosphate36$48,572
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$34,876
FarxigaDapagliflozin Propanediol35$31,335
JanumetSitagliptin Phos/Metformin Hcl14$23,350
Advair HfaFluticasone Propion/Salmeterol28$19,415
Spiriva HandihalerTiotropium Bromide15$14,925
Tresiba Flextouch U-100Insulin Degludec19$13,770
Breo ElliptaFluticasone/Vilanterol19$12,672
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$9,208
Lantus SolostarInsulin Glargine,hum.Rec.Anlog82$9,115
Albuterol Sulfate HfaAlbuterol Sulfate325$8,862

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$66$132,796104 claims
Novo NordiskOzempic$92$118,51097 claims
PfizerEliquis$55$95,12184 claims
MerckJanuvia, Janumet$16$71,92350 claims
Boehringer IngelheimJardiance$45$50,00639 claims
GSKTrelegy Ellipta, Breo Ellipta$12$47,54864 claims
NovartisEntresto$12$6,98711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Nassawadox

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →